The authors of the PARADIGM-HF study aimed to answer the question of how much candidate biomarkers, with Gal-3 among them, improved risk prediction when added to comprehensive models, including routinely collected clinical and laboratory variables in HF. Here, LGALS3 is linked to hydrops fetalis.